Cite
HARVARD Citation
Singh, D. et al. (2022). A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma. British journal of clinical pharmacology. 88 (2), pp. 702-712. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Singh, D. et al. (2022). A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma. British journal of clinical pharmacology. 88 (2), pp. 702-712. [Online].